Mdm2 promotes the rapid degradation of p53

被引:3741
|
作者
Haupt, Y
Maya, R
Kazaz, A
Oren, M
机构
[1] WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
[2] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,LAUTENBERG CTR GEN & TUMOR IMMUNOL,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1038/387296a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p53 tumour-suppressor protein exerts antiproliferative effects, including growth arrest and apoptosis, in response to various types of stress'. The activity of p53 is abrogated by mutations that occur frequently in tumours, as well as by several viral and cellular proteins(1,2). The Mdm2 oncoprotein is a potent inhibitor of p53 (ref. 3). Mdm2 binds the transcriptional activation domain of p53 and blocks its ability to regulate target genes(3,4) and to exert antiproliferative effects(4-7). On the other hand, p53 activates the expression of the mdm2 gene(1) in an autoregulatory feedback loop(3). The interval between p53 activation and consequent Mdm2 accumulation defines a time window during which p53 exerts its effects(8). We now report that Mdm2 also promotes the rapid degradation of p53 under conditions in which p53 is otherwise stabilized. This effect of Mdm2 requires binding of p53; moreover, a small domain of p53, encompassing the Mdm2-binding site, confers Mdm2-dependent detstabilization upon heterologous proteins. Raised amounts of Mdm2 strongly repress mutant p53 accumulation in tumour-derived cells. During recovery from DNA damage, maximal Mdm2 induction coincides with rapid p53 loss. We propose that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.
引用
收藏
页码:296 / 299
页数:4
相关论文
共 50 条
  • [1] Mdm2 promotes the rapid degradation of p53
    Ygal Haupt
    Ruth Maya
    Anat Kazaz
    Moshe Oren
    [J]. Nature, 1997, 387 : 296 - 299
  • [2] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    [J]. FEBS LETTERS, 2004, 561 (1-3): : 195 - 201
  • [3] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [4] P53 degradation by Mdm2 - A novel mechanism for regulation of p53 stability
    Nampoothiri, VK
    [J]. CURRENT SCIENCE, 1998, 75 (09): : 875 - 877
  • [5] Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53
    Zhu, QZ
    Yao, JH
    Wani, G
    Wani, MA
    Wani, AA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) : 29695 - 29701
  • [6] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [7] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [8] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    [J]. BLOOD, 2023, 141 (11) : 1237 - 1238
  • [9] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [10] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934